PT - JOURNAL ARTICLE AU - Stanoev, Vladimir AU - Yankov, Georgi AU - Semkov, Anatoli AU - Goranov, Eljuar AU - Petrov, Danail TI - Comparative analysis of the results of surgical treatment for pulmonary metastases from colorectal cancer and metastases from other primary origin AID - 10.1183/13993003.congress-2016.PA2531 DP - 2016 Sep 01 TA - European Respiratory Journal PG - PA2531 VI - 48 IP - suppl 60 4099 - https://publications.ersnet.org//content/48/suppl_60/PA2531.short 4100 - https://publications.ersnet.org//content/48/suppl_60/PA2531.full SO - Eur Respir J2016 Sep 01; 48 AB - Aim: To compare postoperative results after surgery for pulmonary metastases from colorectal carcinoma with them from other extrapulmonary origin.Methods: From Jan 2001 to Dec 2015 were operated on 67 patients, 22 for metastases from colorectal carcinoma. One-stage operations were performed via median sternotomy (7) and bilateral thoracotomies (3), 1 of them with colorectal origin. Two-stage strategy was applied in 6 patients, 3 of them with colorectal origin. Unilateral operation were carried out: metastasectomy in 38 (56.7%), lobectomy in 9 (13.4%), extended lobectomy in 2 (3.0%), sleeve lobectomy in 1 (1.5%) and polysegmental resection in 1 (1.5%). By the patients with colorectal origin were carried out: metastasectomy in 12 (54.5%), lobectomy in 4 (18.2%), extended lobectomy in 1 (4.5%) and polysegmental resection in 1 (4.5%). VATS was applied in 9 (13.4%) patients, 3 (13.6%) of them with colorectal carcinoma.Results: No 30-day postoperative mortality was faced. The mean number of resected metastases was 2.13 per patient, in the group with colorectal origin 1.86. Metastatic mediastinal lymph nodes involvement was found in 9 (13.6%) patients, 3 (13.6%) of them with metastases from colorectal carcinoma. There was no significant difference in long-term results and in prognostic factors between two groups of patients (p=0.578).Survival in months in patients with colorectal cancer and patients with other primary origin.Conclusion: Disease free intervaland number of metastases are the main prognostic factors. Mediastinal lymph nodes involvement is an unfavorable prognostic factor.